Filana Therapeutics, Inc. Accumulated Other Comprehensive Income
Filana Therapeutics, Inc. (FLNA) had Accumulated Other Comprehensive Income of $1.00 thousand as of 2016-09-30, per its 10-Q filed 2016-10-26.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2016-10-26
- 2016-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.00K.
- 2015-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.00K.
- 2015-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.00K.
- 2015-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2016-09-30 | $1.00K 10-Q · filed 2016-10-26 |
| 2015-09-30 | $1.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $1.00K 10-Q · filed 2015-07-23 |
| 2015-03-31 | $1.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $1.00K 10-K · filed 2016-03-03 |
| 2014-09-30 | $1.00K 10-Q · filed 2014-11-05 |
| 2014-03-31 | $1.00K 10-Q · filed 2014-05-07 |
| 2013-12-31 | $1.00K 10-K · filed 2015-02-18 |
| 2013-09-30 | $1.00K 10-Q · filed 2013-11-01 |
| 2013-06-30 | $1.00K 10-Q · filed 2013-08-01 |
| 2013-03-31 | $1.00K 10-Q · filed 2013-04-24 |
| 2012-12-31 | $4.00K 10-K · filed 2014-02-05 |
| 2012-09-30 | $2.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $43.00K 10-Q · filed 2012-08-02 |
| 2012-03-31 | $96.00K 10-Q · filed 2012-05-08 |
| 2011-12-31 | $128.00K 10-K · filed 2013-02-08 |
| 2011-09-30 | $121.00K 10-Q · filed 2011-11-03 |
| 2011-06-30 | $394.00K 10-Q · filed 2011-08-04 |
| 2010-12-31 | $525.00K 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |